| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.3 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |